1-[4-benzoyl-1-(4-methylphenyl)-1H-pyrazol-3-yl]-3-dimethylamino-propenone

ID: ALA1077055

PubChem CID: 45277583

Max Phase: Preclinical

Molecular Formula: C22H21N3O2

Molecular Weight: 359.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-n2cc(C(=O)c3ccccc3)c(C(=O)/C=C/N(C)C)n2)cc1

Standard InChI:  InChI=1S/C22H21N3O2/c1-16-9-11-18(12-10-16)25-15-19(22(27)17-7-5-4-6-8-17)21(23-25)20(26)13-14-24(2)3/h4-15H,1-3H3/b14-13+

Standard InChI Key:  OBOUPYGNURLONI-BUHFOSPRSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    3.7427  -20.4165    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4249  -19.9423    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1828  -19.1494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3538  -19.1341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0825  -19.9175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9403  -18.4204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3520  -17.7054    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1153  -18.4214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7066  -17.7074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8823  -17.7080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4699  -18.4235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8877  -19.1399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7105  -19.1357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7263  -21.2413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0042  -21.6347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9874  -22.4587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6941  -22.8862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4191  -22.4836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4323  -21.6609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8734  -18.7012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6082  -19.0765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8307  -17.8773    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3005  -18.6279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0352  -19.0032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7276  -18.5546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0775  -19.8271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6787  -23.7111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 13  8  1  0
  1 14  1  0
  6  7  2  0
 14 15  2  0
  1  2  1  0
 15 16  1  0
  6  8  1  0
 16 17  2  0
  3  4  1  0
 17 18  1  0
  8  9  2  0
 18 19  2  0
 19 14  1  0
  4  5  2  0
  3 20  1  0
  9 10  1  0
 20 21  1  0
  5  1  1  0
 20 22  2  0
 10 11  2  0
 21 23  2  0
  2  3  2  0
 23 24  1  0
 11 12  1  0
 24 25  1  0
  4  6  1  0
 24 26  1  0
 12 13  2  0
 17 27  1  0
M  END

Associated Targets(non-human)

Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC-38 (857 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Top2a DNA topoisomerase II alpha (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1634AlogP: 3.67#Rotatable Bonds: 6
Polar Surface Area: 55.20Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.32CX LogD: 4.32
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.50Np Likeness Score: -1.25

References

1. Riyadh SM, Farghaly TA, Abdallah MA, Abdalla MM, Abd El-Aziz MR..  (2010)  New pyrazoles incorporating pyrazolylpyrazole moiety: synthesis, anti-HCV and antitumor activity.,  45  (3): [PMID:20022411] [10.1016/j.ejmech.2009.11.050]

Source